Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Cash from Discontinued Operations: 2018-2021

Historic Cash from Discontinued Operations for Cumberland Pharmaceuticals (CPIX) over the last 4 years, with Dec 2021 value amounting to $2.0 million.

  • Cumberland Pharmaceuticals' Cash from Discontinued Operations fell 62.78% to $503,318 in Q4 2021 from the same period last year, while for Dec 2021 it was $2.0 million, marking a year-over-year decrease of 43.31%. This contributed to the annual value of $2.0 million for FY2021, which is 43.31% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Cash from Discontinued Operations stood at $2.0 million for FY2021, which was down 43.31% from $3.5 million recorded in FY2020.
  • Over the past 5 years, Cumberland Pharmaceuticals' Cash from Discontinued Operations peaked at $5.5 million during FY2019, and registered a low of $2.0 million during FY2021.
  • Its 3-year average for Cash from Discontinued Operations is $3.7 million, with a median of $3.5 million in 2020.
  • Its Cash from Discontinued Operations has fluctuated over the past 5 years, first climbed by 22.38% in 2019, then slumped by 43.31% in 2021.
  • Cumberland Pharmaceuticals' Cash from Discontinued Operations (Yearly) stood at $4.5 million in 2018, then increased by 22.38% to $5.5 million in 2019, then plummeted by 36.17% to $3.5 million in 2020, then slumped by 43.31% to $2.0 million in 2021.